Ublituximab
TG1101-RMS302
Phase 3 mab active
Quick answer
Ublituximab for Relapsing Multiple Sclerosis (RMS) is a Phase 3 program (mab) at TG THERAPEUTICS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Relapsing Multiple Sclerosis (RMS)
- Phase
- Phase 3
- Modality
- mab
- Status
- active